Alnylam Pharmaceuticals
ALNY
#559
Rank
A$63.38 B
Marketcap
A$477.95
Share price
-0.16%
Change (1 day)
20.99%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company